The CO-releasing molecule CORM-3 protects adult cardiomyocytes against hypoxia-reoxygenation by modulating pH restoration.


Journal

European journal of pharmacology
ISSN: 1879-0712
Titre abrégé: Eur J Pharmacol
Pays: Netherlands
ID NLM: 1254354

Informations de publication

Date de publication:
05 Nov 2019
Historique:
received: 13 05 2019
revised: 26 08 2019
accepted: 02 09 2019
pubmed: 7 9 2019
medline: 7 3 2020
entrez: 7 9 2019
Statut: ppublish

Résumé

Several studies have reported that CORM-3, a water-soluble carbon monoxide releasing molecule, elicits cardioprotection against myocardial infarction but the mechanism remains to be investigated. Numerous reports indicate that inhibition of pH regulators, the Na

Identifiants

pubmed: 31491405
pii: S0014-2999(19)30588-6
doi: 10.1016/j.ejphar.2019.172636
pii:
doi:

Substances chimiques

Culture Media 0
Decanoic Acids 0
Flavonoids 0
Hydroxy Acids 0
KATP Channels 0
Organometallic Compounds 0
Protective Agents 0
tricarbonylchloro(glycinato)ruthenium(II) 0
5-hydroxydecanoic acid 624-00-0
Carbon Monoxide 7U1EE4V452
MAP Kinase Kinase 1 EC 2.7.12.2
MAP Kinase Kinase 2 EC 2.7.12.2
Map2k1 protein, mouse EC 2.7.12.2
Map2k2 protein, mouse EC 2.7.12.2
2-(2-amino-3-methoxyphenyl)-4H-1-benzopyran-4-one SJE1IO5E3I

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

172636

Informations de copyright

Copyright © 2019 Elsevier B.V. All rights reserved.

Auteurs

Lolita Portal (L)

U955-IMRB, Equipe 03, Inserm, UPEC, Ecole Nationale Vétérinaire d'Alfort, Créteil, France.

Didier Morin (D)

U955-IMRB, Equipe 03, Inserm, UPEC, Ecole Nationale Vétérinaire d'Alfort, Créteil, France.

Roberto Motterlini (R)

U955-IMRB, Equipe 12, Inserm, UPEC, Créteil, France.

Bijan Ghaleh (B)

U955-IMRB, Equipe 03, Inserm, UPEC, Ecole Nationale Vétérinaire d'Alfort, Créteil, France. Electronic address: bijan.ghaleh@inserm.fr.

Sandrine Pons (S)

U955-IMRB, Equipe 03, Inserm, UPEC, Ecole Nationale Vétérinaire d'Alfort, Créteil, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH